Form D · Biotechnology
Alector LLC
San Francisco, CA · CIK 0001653087
Offering snapshot reported Sep 16, 2015 · SEC filing
- Reported sold
- $32.3M Offering amount: $32.3M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2015 | Initial | $32,275,003 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-247718
Source: Form D, filed Sep 16, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tillman Gerngross | Director |
| Carl Gordon | Director |
| Terry Mc Guire | Director |
| Arnon Rosenthal | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
953 Indiana Street
San Francisco, CA, 94107
San Francisco, CA, 94107